StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Sarepta Therapeutics (SRPT) Active Ahead of Today's FDA AdCom and Expected Halt
April 25, 2016 6:40 AM
Sarepta Therapeutics (NASDAQ: SRPT) is trading up ahead of ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
FDA
Trader Talk
Next Articles
FDA Panel 6 YES, 7 NO That Eteplirsen Shows Clinical Benefit (SRPT)
April 25, 2016 6:12 PM
FDA Panel Starts Getting Cautious on Sarepta's (SRPT) Eteplirsen
April 25, 2016 12:19 PM
Sarepta Therapeutics (SRPT) Halted Ahead of FDA AdCom
April 25, 2016 7:02 AM
Baird 'Incrementally Positive' on Sarepta (SRPT) Following 'Shocking Move' by FDA
April 22, 2016 2:57 PM
Sarepta (SRPT) Voting Questions Rekindle Hope, but RBC Still Expects a Negative Panel
April 22, 2016 2:22 PM
FDA Draft Questions Changes Calculus on Sarepta (SRPT) Approval 'to Some Extent' - Janney Montgomery Scott
April 22, 2016 1:35 PM
Leerink Remains Skeptical Despite FDA Draft Questions on Sarepta (SRPT)
April 22, 2016 1:28 PM
Sarepta Therapeutics (SRPT) Resumes Trading Following Volatility Spike
April 22, 2016 12:27 PM
Sarepta Therapeutics (SRPT) triggers limit-up, limit-down trading pause
April 22, 2016 12:21 PM
Sarepta Therapeutics (SRPT) Continues Surge Higher as FDA Ads Voting Question
April 22, 2016 12:21 PM
Sarepta Therapeutics (SRPT) Sees Strong Mid-Day Upside
April 22, 2016 12:03 PM
